Compare ARK Genomic Revolution ETF (ARKG) vs FirstEnergy Corp. (FE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs FirstEnergy Corp. — how do they compare? ARK Genomic Revolution ETF trades at $40.91, while FirstEnergy Corp. trades at $48.47 (market cap $27.72B). The key difference: FirstEnergy Corp. pays a 3.88% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, FirstEnergy Corp. nearer its low. Which is the better fit depends on your goals.
| ARKG | FE | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $51.91 |
52-Week Low | $23.09 | $40.30 |
Market Cap | — | $27.72B |
Enterprise Value | — | $55.73B |
Dividend Yield | — | 3.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
FirstEnergy (FE) trades at $47.92, up 0.61% with neutral technical signals. The company shows steady revenue growth to $15.09B in 2025 and a net income margin of 6.86%, though cash flow remains negative. Recent news highlights opportunities from surging data center demand and a $36B investment plan for grid upgrades. Analyst consensus is mixed with a $52 price target, indicating potential upside from current levels.
Outlook is cautiously optimistic given FE's strategic investments and data center tailwinds, but risks include regulatory uncertainty and high debt levels. The stock presents a balanced opportunity for investors seeking utility exposure with growth potential, though monitoring earnings execution and capex efficiency is crucial for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →
